| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.01 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |